WO1997024138A3 - Medical use of proteases - Google Patents
Medical use of proteases Download PDFInfo
- Publication number
- WO1997024138A3 WO1997024138A3 PCT/GB1996/003089 GB9603089W WO9724138A3 WO 1997024138 A3 WO1997024138 A3 WO 1997024138A3 GB 9603089 W GB9603089 W GB 9603089W WO 9724138 A3 WO9724138 A3 WO 9724138A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- proteases
- medical use
- pathways
- modulators
- intracellular signal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21004—Trypsin (3.4.21.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/22—Cysteine endopeptidases (3.4.22)
- C12Y304/22002—Papain (3.4.22.2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96942449A EP0876153A2 (en) | 1995-12-29 | 1996-12-13 | Medical use of proteases |
JP9524091A JP2000502697A (en) | 1995-12-29 | 1996-12-13 | Use of proteases in medicine |
AU11818/97A AU1181897A (en) | 1995-12-29 | 1996-12-13 | Medical use of proteases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9526691.2 | 1995-12-29 | ||
GBGB9526691.2A GB9526691D0 (en) | 1995-12-29 | 1995-12-29 | Medical use of proteases |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997024138A2 WO1997024138A2 (en) | 1997-07-10 |
WO1997024138A3 true WO1997024138A3 (en) | 1997-10-16 |
Family
ID=10786186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1996/003089 WO1997024138A2 (en) | 1995-12-29 | 1996-12-13 | Medical use of proteases |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0876153A2 (en) |
JP (1) | JP2000502697A (en) |
AU (1) | AU1181897A (en) |
GB (1) | GB9526691D0 (en) |
WO (1) | WO1997024138A2 (en) |
ZA (1) | ZA9610433B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1012305A1 (en) | 1997-02-25 | 2000-06-28 | Cortecs (UK) Limited | Component of bromelain |
US20020102253A1 (en) | 1997-02-25 | 2002-08-01 | Mynott Tracey Lehanne | Component of bromelain |
DE19726255C2 (en) * | 1997-06-20 | 2000-03-16 | Mucos Pharma Gmbh & Co | Influence of cytokines by proteolytic enzymes and rutoside |
DE19726244C2 (en) * | 1997-06-20 | 2000-03-02 | Mucos Pharma Gmbh & Co | Use of proteolytic enzymes and rutoside to prevent or treat graft rejection |
DE19726254C2 (en) * | 1997-06-20 | 1999-10-21 | Mucos Pharma Gmbh & Co | Tolerance induction through proteases |
DE19957318A1 (en) * | 1999-11-29 | 2001-06-21 | Mucos Pharma Gmbh & Co | Influence of TGF-beta by proteolytic enzymes |
DE10018980A1 (en) * | 2000-04-17 | 2001-11-08 | Mucos Pharma Gmbh & Co | Prophylaxis and therapy of diabetes mellitus I using proteolytic enzymes |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996000082A1 (en) * | 1994-06-24 | 1996-01-04 | Cortecs Limited | Medical use of bromelain |
-
1995
- 1995-12-29 GB GBGB9526691.2A patent/GB9526691D0/en active Pending
-
1996
- 1996-12-11 ZA ZA9610433A patent/ZA9610433B/en unknown
- 1996-12-13 AU AU11818/97A patent/AU1181897A/en not_active Abandoned
- 1996-12-13 JP JP9524091A patent/JP2000502697A/en active Pending
- 1996-12-13 EP EP96942449A patent/EP0876153A2/en not_active Withdrawn
- 1996-12-13 WO PCT/GB1996/003089 patent/WO1997024138A2/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996000082A1 (en) * | 1994-06-24 | 1996-01-04 | Cortecs Limited | Medical use of bromelain |
Non-Patent Citations (7)
Title |
---|
"Systematische Enzymtherapie: Grosse Zukunft zu erwarten", THERAPIEWOCHE ÖSTERREICH, vol. 7, no. 2, 1992, pages 65 - 72, XP000652911 * |
A.GESCHER: "Modulators of signal transduction as cancer chemotherapeutic agents - novel mechanisms and toxicities", TOXICOLOGY LETTERS, vol. 82/83, December 1995 (1995-12-01), pages 159 - 163, XP000652605 * |
DARIO C. ALTIERI: "Proteases and protease receptors in modulation of leukocyte effector functions", J. LEUKOC. BIOL., vol. 58, no. 2, 1995, pages 120 - 127, XP000652620 * |
DENIS GODIN ET AL.: "Mode of action of thrombin in the rat aorta", BR. J. PHARMACOL., vol. 115, no. 6, July 1995 (1995-07-01), pages 903 - 908, XP000652621 * |
ELENA GABRIELESCU: "An integrative approach to the proteolytic control of the cell-mediated cytotoxicity", ROUM. ARCH. MICROBIOL. IMMUNOL., vol. 51, no. 1-2, 1992, pages 33 - 51, XP000652932 * |
G.STAUDER: "Pharmacological effects of oral enzyme combinations", CASOPIS LEKARU CESKYCH, vol. 134, no. 19, 1995, pages 620 - 624, XP000652595 * |
M.T.ALONSO ET AL.: "Leupeptin does not affect the normal signal transduction mechanism in platelets", FEBS LETT., vol. 244, no. 2, 1989, pages 407 - 410, XP000652613 * |
Also Published As
Publication number | Publication date |
---|---|
WO1997024138A2 (en) | 1997-07-10 |
JP2000502697A (en) | 2000-03-07 |
AU1181897A (en) | 1997-07-28 |
ZA9610433B (en) | 1998-06-11 |
GB9526691D0 (en) | 1996-02-28 |
EP0876153A2 (en) | 1998-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7867994A (en) | Hemofiltration of mediator-related diseases | |
AU635961B2 (en) | Novel peptidase and isomerase inhibitors | |
IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
AU5382996A (en) | Disposable pull-on pant | |
AU6639096A (en) | Corneal irrigation cannula | |
AU4180593A (en) | The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura | |
EP0690673A4 (en) | Systemic gene treatment of connective tissue diseases | |
HK1011024A1 (en) | Phosphorus derivatives to treat aids. | |
NO965564L (en) | Medical application of bromelain | |
AU5967896A (en) | Peptidyl heterocycles useful in the treatment of thrombin re lated disorders | |
AU7833194A (en) | Use of triclosan phosphates for the treatment of gastrointestinal disorders due to heliobacter infection | |
ZA964761B (en) | Peptidyl heterocycles useful in the treatment of thrombin related disorders. | |
WO1997024138A3 (en) | Medical use of proteases | |
AU3555295A (en) | Game of chance | |
AU4704797A (en) | Use of benzopyranols to treat neurological disorders | |
AU4202096A (en) | The use of sertraline to treat cancer patients | |
AU6147296A (en) | Therapeutic use of acetazolamide for the treatment of brain edema | |
HU9502623D0 (en) | Use of substituted alkyl-nitrates for the treatment of pathologically increased intraocular pressure | |
AU3242293A (en) | Diagnosis of hereditary retinal degenerative diseases | |
EP0784983A3 (en) | Use of extracellular hemoglobin | |
AU2754997A (en) | The treatment of plant diseases | |
AU2233495A (en) | Treatment or diagnosis of abnormal signal transduction disorders | |
WO1994024279A3 (en) | Agents for the prevention and treatment of huntington's disease and other neurological disorders | |
AU6657096A (en) | Imido peroxides as initiators of polymerization processes | |
MX9700209A (en) | Medical use of bromelain. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996942449 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1996942449 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996942449 Country of ref document: EP |